Anna M. Y. Yamamura - Concepedia

Author

Anna M. Y. Yamamura

Also Known As

Anna M. Y. Yamamura, Anna M. Yoshida Yamamura, Anna M.Y Yamamura, Anna M.Y. Yamamura, Anna Maya Y. Yamamura, Anna Maya Yoshida Yamamura, Anna Yamamura, Yamamura,Anna M. Yoshida

Publications

730

Citations

H-Index

Concepts

All Affiliations

Fundação Oswaldo Cruz Escola Nacional de Saúde Pública Secretaria da Saúde Instituto de Biologia do Exército

About

Anna M. Y. Yamamura is an author at Fundação Oswaldo Cruz specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	415
2	Immunology	7	7	353
3	Epidemiology	2	2	62
4	Public Health	1	1	47
5	Cell Biology	1	1	42

Anna M. Y. Yamamura

Publications

725

Citations

H-Index

Page 1

	Year	Citations
17DD yellow fever vaccine Reinaldo de Menezes Martins, Maria de Lourdes S. Maia, Roberto Farias, Human Vaccines & Immunotherapeutics	2013	115
Mutual interference on the immune response to yellow fever vaccine and a combined vaccine against measles, mumps and rubella Juliana Romualdo Nascimento Silva, Luiz Antônio Bastos Camacho, Marilda Mendonça Siqueira, Vaccine	2011	95
Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline Ana Carolina Campi‐Azevedo, Paula de Almeida Estevam, Jordana Grazziela Alves Coelho-dos-Reis, BMC Infectious Diseases	2014	88
Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine Isabel Cristina Aparecida Stefano, Helena Keiko Sato, Cláudio Mendes Pannuti, Vaccine VaccinationRecent ImmunizationVaccine DevelopmentFever VaccineVaccine Target	1999	74
Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies Marisol Simões, Luiz Antônio Bastos Camacho, Anna M. Y. Yamamura, Biologicals VaccinationDiagnostic VirologyViral DiagnosticsDiagnostic TestImmunology	2012	72
Pressure-inactivated yellow fever 17DD virus: Implications for vaccine development Luciane P. Gaspar, Ygara S. Mendes, Anna M. Y. Yamamura, Journal of Virological Methods VaccinationVaccine DevelopmentImmunologyVirologyMedicine	2008	60
Risk Factors for Dengue Virus Infection in Rural Amazonia: Population-based Cross-sectional Surveys Mônica da Silva‐Nunes, Vanda A. F. de Souza, Cláudio Mendes Pannuti, American Journal of Tropical Medicine and Hygiene Dengue VirusVirus EpidemiologyArbovirusVector-borne PathogenVector Borne Disease	2008	47
An inactivated yellow fever 17DD vaccine cultivated in Vero cell cultures Renata Carvalho Pereira, Andrea N. M. R. Silva, Marta Cristina O. Souza, Vaccine VaccinationVaccine DevelopmentInactivated YellowImmunologyMicrobiology	2015	45
DNA Vaccines against Dengue Virus Type 2 Based on Truncate Envelope Protein or Its Domain III Adriana de Souza Azevedo, Anna M. Y. Yamamura, Marcos S. Freire, PLoS ONE VaccinationTruncate Envelope ProteinVaccine DevelopmentNeurovirologyPe1d2 Vaccine	2011	42
Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity Marcos S. Freire, G.F. Mann, Renato Sérgio Marchevsky, Vaccine VaccinationVaccine DevelopmentPoultry DiseaseImmunologyVirology	2004	37

Page 1